Disruption of PVN p44/42 mitogen-activated protein kinase (MAPK) signal transduction during the early phase of slow pressor Ang II infusion, prior to the development of hypertension, attenuates Ang II hypertension and sympathoexcitation, but does not reduce Ang II-evoked increases in PIC [20]. The gene discussed is AGT; the disease is hypertensive disorder.